{"id":59036,"date":"2024-02-12T02:38:51","date_gmt":"2024-02-12T02:38:51","guid":{"rendered":"https:\/\/news.pakistaninewspaperlist.com\/coloplast-a-s-allocation-of-share-options\/"},"modified":"2024-02-12T02:38:51","modified_gmt":"2024-02-12T02:38:51","slug":"coloplast-a-s-allocation-of-share-options","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/coloplast-a-s-allocation-of-share-options\/","title":{"rendered":"Coloplast A\/S – Allocation of Share Options"},"content":{"rendered":"
\n

Report on transactions of executives and related parties in Coloplast shares and related securities<\/strong><\/p>\n

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.<\/p>\n

The below transactions concern allocation of share options.<\/p>\n

For further details, reference is made to Coloplast\u2019s Remuneration Policy. The policy is available on the group website at this address:<\/p>\n

https:\/\/investor.coloplast.com\/investor-relations\/governance\/policies_and_positions\/<\/a><\/u><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\n Details of the person discharging managerial responsibilities\/person closely associated<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Kristian Villumsen<\/em> <\/td>\n<\/tr>\n
2<\/strong> <\/td>\n Reason for the notification<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Position\/status <\/td>\n President & CEO<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Initial notification\/Amendment <\/td>\n Initial notification<\/em> <\/td>\n<\/tr>\n
3<\/strong> <\/td>\n Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Coloplast A\/S (CVR-no.: 69749917)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n LEI <\/td>\n 529900NN7SOJ5QG82X67<\/em> <\/td>\n<\/tr>\n
4<\/strong> <\/td>\n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Description of the financial instrument, type of instrument <\/td>\n Share options relating to B shares <\/em> <\/td>\n<\/tr>\n
Identification code <\/td>\n ISIN: DK0060448595 (B shares)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Nature of the transaction <\/td>\n Share option allocation<\/em> <\/td>\n<\/tr>\n
c) <\/td>\n Price and volume <\/td>\n Price <\/td>\n Volume <\/td>\n<\/tr>\n
0.00<\/em> <\/td>\n 49,153<\/em> <\/td>\n<\/tr>\n
d) <\/td>\n Aggregated information <\/td>\n \u00a0<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aggregated volume <\/td>\n 49,153 <\/em>share options<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Price <\/td>\n DKK 0.00<\/em> <\/td>\n<\/tr>\n
e) <\/td>\n Date of the transaction <\/td>\n 2024-02-09, 13:30 UTC<\/em> <\/td>\n<\/tr>\n
f) <\/td>\n Place of the transaction <\/td>\n Outside a trading venue<\/em> <\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
1<\/strong> <\/td>\n Details of the person discharging managerial responsibilities\/person closely associated<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Anders Lonning-Skovgaard<\/em> <\/td>\n<\/tr>\n
2<\/strong> <\/td>\n Reason for the notification<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Position\/status <\/td>\n Executive Vice President & CFO<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Initial notification\/Amendment <\/td>\n Initial notification<\/em> <\/td>\n<\/tr>\n
3<\/strong> <\/td>\n Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Coloplast A\/S (CVR-no.: 69749917)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n LEI <\/td>\n 529900NN7SOJ5QG82X67<\/em> <\/td>\n<\/tr>\n
4<\/strong> <\/td>\n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Description of the financial instrument, type of instrument <\/td>\n Share options relating to B shares <\/em> <\/td>\n<\/tr>\n
Identification code <\/td>\n ISIN: DK0060448595 (B shares)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Nature of the transaction <\/td>\n Share option allocation<\/em> <\/td>\n<\/tr>\n
c) <\/td>\n Price and volume <\/td>\n Price <\/td>\n Volume <\/td>\n<\/tr>\n
0.00<\/em> <\/td>\n 25,021<\/em> <\/td>\n<\/tr>\n
d) <\/td>\n Aggregated information <\/td>\n \u00a0<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aggregated volume <\/td>\n 25,021 <\/em>share options<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Price <\/td>\n DKK 0.00<\/em> <\/td>\n<\/tr>\n
e) <\/td>\n Date of the transaction <\/td>\n 2024-02-09, 13:30 UTC<\/em> <\/td>\n<\/tr>\n
f) <\/td>\n Place of the transaction <\/td>\n Outside a trading venue<\/em> <\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
1<\/strong> <\/td>\n Details of the person discharging managerial responsibilities\/person closely associated<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Paul Marcun<\/em> <\/td>\n<\/tr>\n
2<\/strong> <\/td>\n Reason for the notification<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Position\/status <\/td>\n Executive Vice President, Growth<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Initial notification\/Amendment <\/td>\n Initial notification<\/em> <\/td>\n<\/tr>\n
3<\/strong> <\/td>\n Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Coloplast A\/S (CVR-no.: 69749917)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n LEI <\/td>\n 529900NN7SOJ5QG82X67<\/em> <\/td>\n<\/tr>\n
4<\/strong> <\/td>\n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Description of the financial instrument, type of instrument <\/td>\n Share options relating to B shares <\/em> <\/td>\n<\/tr>\n
Identification code <\/td>\n ISIN: DK0060448595 (B shares)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Nature of the transaction <\/td>\n Share option allocation<\/em> <\/td>\n<\/tr>\n
c) <\/td>\n Price and volume <\/td>\n Price <\/td>\n Volume <\/td>\n<\/tr>\n
0.00<\/em> <\/td>\n 24,909<\/em> <\/td>\n<\/tr>\n
d) <\/td>\n Aggregated information <\/td>\n \u00a0<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aggregated volume <\/td>\n 24,909 <\/em>share options<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Price <\/td>\n DKK 0.00<\/em> <\/td>\n<\/tr>\n
e) <\/td>\n Date of the transaction <\/td>\n 2024-02-09, 13:30 UTC<\/em> <\/td>\n<\/tr>\n
f) <\/td>\n Place of the transaction <\/td>\n Outside a trading venue<\/em> <\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
1<\/strong> <\/td>\n Details of the person discharging managerial responsibilities\/person closely associated<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Allan Rasmussen<\/em> <\/td>\n<\/tr>\n
2<\/strong> <\/td>\n Reason for the notification<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Position\/status <\/td>\n Executive Vice President, Global Operations<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Initial notification\/Amendment <\/td>\n Initial notification<\/em> <\/td>\n<\/tr>\n
3<\/strong> <\/td>\n Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Coloplast A\/S (CVR-no.: 69749917)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n LEI <\/td>\n 529900NN7SOJ5QG82X67<\/em> <\/td>\n<\/tr>\n
4<\/strong> <\/td>\n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Description of the financial instrument, type of instrument <\/td>\n Share options relating to B shares <\/em> <\/td>\n<\/tr>\n
Identification code <\/td>\n ISIN: DK0060448595 (B shares)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Nature of the transaction <\/td>\n Share option allocation<\/em> <\/td>\n<\/tr>\n
c) <\/td>\n Price and volume <\/td>\n Price <\/td>\n Volume <\/td>\n<\/tr>\n
0.00<\/em> <\/td>\n 21,828<\/em> <\/td>\n<\/tr>\n
d) <\/td>\n Aggregated information <\/td>\n \u00a0<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aggregated volume <\/td>\n 21,828 <\/em>share options<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Price <\/td>\n DKK 0.00<\/em> <\/td>\n<\/tr>\n
e) <\/td>\n Date of the transaction <\/td>\n 2024-02-09, 13:30 UTC<\/em> <\/td>\n<\/tr>\n
f) <\/td>\n Place of the transaction <\/td>\n Outside a trading venue<\/em> <\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
1<\/strong> <\/td>\n Details of the person discharging managerial responsibilities\/person closely associated<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Nicolai Buhl Andersen<\/em> <\/td>\n<\/tr>\n
2<\/strong> <\/td>\n Reason for the notification<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Position\/status <\/td>\n Executive Vice President, Innovation<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Initial notification\/Amendment <\/td>\n Initial notification<\/em> <\/td>\n<\/tr>\n
3<\/strong> <\/td>\n Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Name <\/td>\n Coloplast A\/S (CVR-no.: 69749917)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n LEI <\/td>\n 529900NN7SOJ5QG82X67<\/em> <\/td>\n<\/tr>\n
4<\/strong> <\/td>\n Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/strong> <\/td>\n<\/tr>\n
a) <\/td>\n Description of the financial instrument, type of instrument <\/td>\n Share options relating to B shares <\/em> <\/td>\n<\/tr>\n
Identification code <\/td>\n ISIN: DK0060448595 (B shares)<\/em> <\/td>\n<\/tr>\n
b) <\/td>\n Nature of the transaction <\/td>\n Share option allocation<\/em> <\/td>\n<\/tr>\n
c) <\/td>\n Price and volume <\/td>\n Price <\/td>\n Volume <\/td>\n<\/tr>\n
0.00<\/em> <\/td>\n 20,615<\/em> <\/td>\n<\/tr>\n
d) <\/td>\n Aggregated information <\/td>\n \u00a0<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aggregated volume <\/td>\n 20,615 <\/em>share options<\/em> <\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Price <\/td>\n DKK 0.00<\/em> <\/td>\n<\/tr>\n
e) <\/td>\n Date of the transaction <\/td>\n 2024-02-09, 13:30 UTC<\/em> <\/td>\n<\/tr>\n
f) <\/td>\n Place of the transaction <\/td>\n Outside a trading venue<\/em> <\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n

\u00a0<\/p>\n

For further information, please contact
<\/strong><\/p>\n

Investors and analysts
<\/strong><\/em>Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111<\/p>\n

Aleksandra Dimovska
Senior Director, Investor Relations
Tel. +45 4911 1800 \/ +45 4911 2458
Email: dkadim@coloplast.com<\/a><\/p>\n

Kristine Husted Munk
Senior Manager, Investor Relations
Tel. +45 4911 1800 \/ +45 4911 3266
Email: dkkhu@coloplast.com<\/a><\/p>\n

Press and media<\/strong><\/em>
Peter M\u00f8nster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com<\/a><\/p>\n

Address<\/strong><\/em>
Coloplast A\/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917<\/p>\n

Website<\/em><\/strong>
www.coloplast.com<\/a><\/p>\n

\u00a0<\/p>\n

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.<\/p>\n

Coloplast was founded on passion, ambition, and commitment. We were born from a nurse\u2019s wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice and Respiratory Care.<\/p>\n

The Coloplast logo is a registered trademark of Coloplast A\/S. \u00a9 2024-02.<\/p>\n

All rights reserved Coloplast A\/S, 3050 Humlebaek, Denmark.<\/p>\n